Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
Adalimumab | Crohn's & Colitis UK
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
Adalimumab | Crohn's & Colitis UK
Selection of TNF inhibitor. a For example, complete blood count,... | Download Scientific Diagram
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives - The Lancet Gastroenterology & Hepatology
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Adalimumab (Humira) Information sheet | IBD Clinic
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Monitoring of Novel Therapies in Rheumatology | RheumNow
Adalimumab
Available now: The complete package for Therapeutic Drug Monitoring
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Momenta ramps up biosim pressure on AbbVie's Humira with phase 3 psoriasis win | Fierce Pharma
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
TNFα Therapeutic Drug Monitoring - Calprotectin
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
